Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Positieve resultaten met videocamera als epilepsie-alarmsysteem
mei 2020 | Epilepsie